Rafael holdings announces inducement grant under nyse rule 303a.08

Newark, n.j., sept. 17, 2021 /prnewswire/ -- rafael holdings, inc., (nyse: rfl), a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its barer institute and investment in rafael pharmaceuticals, inc., announced today it made a grant to patrick fabbio of options to purchase 105,602 shares of class b common stock of the company with an exercise price equal to $36.32, the closing price of the class b common stock on september 16, 2021, the trading day prior to the grant.
RFL Ratings Summary
RFL Quant Ranking